Sign in
Stories
Biosimulation Market to Reach USD 10.80 Billion by 2032
Share
ADME Toxicology Testing Market Growth
AI-Driven Discovery and Insurance Innova...
AI-Driven Protein Design Revolutionizes ...
AI Partnerships Drive Drug Discovery
AscellaHealth Forecasts Robust Outlook f...
BenevolentAI Unveils 2023 Results
Overview
API
The global biosimulation market is projected to reach USD 10.80 billion by 2032, with a CAGR of 14.50%. North America currently dominates the market, while the Asia Pacific region is expected to experience the fastest growth. Rising costs of drug discovery and increasing investments in pharmaceutical research and development are key factors driving market growth.
Ask a question
How do biosimulation technologies impact the development of new drugs?
What are the main challenges faced by the biosimulation market?
What are the potential economic implications of the biosimulation market's growth?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Coverage